Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The index has shown a price loss of -66.29% this year. Over the last six months, there has been a stronger performance of -52.35%. The price of BFRI leaped by -20.86% during the last 30 days period. For the last 5-days stocks have slided -3.22%.
Biofrontera Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $5.28 on 11/01/23 and the lowest value was $0.61 on 02/08/24.
52-week price history of BFRI Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Biofrontera Inc’s current trading price is -82.31% away from its 52-week high, while its distance from the 52-week low is 53.10%. The stock’s price range during this period has varied between$0.61 and $5.28. The Biofrontera Inc’s shares, which operate in the Healthcare, saw a trading volume of around 2.43 million for the day, a figure considerably higher than their average daily volume of 0.37 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Biofrontera Inc (BFRI) has experienced a quarterly decline of -17.37% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 5.18M and boasts a workforce of 85 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.0666, with a change in price of -0.0561. Similarly, Biofrontera Inc recorded 280,417 in trading volume during the last 100 days, posting a change of -5.67%.
BFRI’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for BFRI stands at 0.13. Similarly, the long-term debt-to-equity ratio is also 0.04.
BFRI Stock Stochastic Average
Biofrontera Inc’s raw stochastic average for the past 50 days is presently 32.96%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 44.35%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 36.31% and 34.92%, respectively.
